Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. SPCX
4. NVDA
5. USO
6. RKLB
7. NDAQ
8. MH
9. CTVFF
10. BBW

Go back to Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

Medtronic, Inc. (MDT) PT Lowered to $124 at Needham & Company

February 22, 2022 1:59 PM EST

Needham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $124.00 (from $128.00) while maintaining a Buy rating following earnings.

The analyst commented, "MDT's F3Q22 revenue missed consensus while its EPS beat consensus and organic revenue growth slowed... More